Literature DB >> 12115113

Linezolid-induced pure red blood cell aplasia.

Thomas Monson, Steven A Schichman, Clive S Zent.   

Abstract

We report a case of reversible pure red blood cell aplasia that developed in a patient who had received 8 weeks of linezolid therapy.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12115113     DOI： 10.1086/340982

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.

Authors:  Glòria Garrabou; Alejandro Soriano; Sònia López; Jordi P Guallar; Marta Giralt; Francesc Villarroya; Jose A Martínez; Jordi Casademont; Francesc Cardellach; Josep Mensa; Oscar Miró
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid.

Authors:  Alex Soriano; Mar Ortega; Sebastián García; Georgina Peñarroja; Albert Bové; Miguel Marcos; Juan C Martínez; José A Martínez; Josep Mensa
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

3.  Pancytopenia due to linezolid treatment.

Authors:  Emine Parlak; Hüseyin Tan
Journal:  Turk Pediatri Ars       Date:  2015-09-01

4.  Influence of Mitochondrial Genetics on the Mitochondrial Toxicity of Linezolid in Blood Cells and Skin Nerve Fibers.

Authors:  G Garrabou; À Soriano; T Pinós; J Casanova-Mollà; D Pacheu-Grau; C Morén; E García-Arumí; M Morales; E Ruiz-Pesini; M Catalán-Garcia; J C Milisenda; E Lozano; A L Andreu; J Montoya; J Mensa; F Cardellach
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

5.  Clinical update on linezolid in the treatment of Gram-positive bacterial infections.

Authors:  Sally Ager; Kate Gould
Journal:  Infect Drug Resist       Date:  2012-06-25       Impact factor: 4.003

6.  Linezolid Induced Twice Pure Red Cell Aplasia in a Patient with Central Nervous System Infection after Allogeneic Stem Cell Transplantation.

Authors:  Wenqing Hu; Bing Shi; Lihui Liu; Shengke He; Liping Ye; DengMei Tian; Yongqing Zhang
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  Linezolid-Induced Pure Red Cell Aplasia: A Case Report.

Authors:  Xiao-Yan Yang; Lin Chen; Ji-Na Gu; Cheng-Jun Zeng; Dan-Mei Pan
Journal:  Infect Drug Resist       Date:  2022-07-20       Impact factor: 4.177

Review 8.  Linezolid-induced pure red cell aplasia: a case report and literature review.

Authors:  Zhuanbo Luo; Ning Xu; Yun Wang; Xiaoping Huang; Chao Cao; Lei Chen
Journal:  J Int Med Res       Date:  2018-10-01       Impact factor: 1.671

Review 9.  Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria.

Authors:  Amaylia Oehadian; Prayudi Santoso; Dick Menzies; Rovina Ruslami
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.